Overall, these findings suggest that while SIRT7 supports anti-tumor immunity—partly by regulating metabolic programs in T cells—it may also reshape the tumor microenvironment through distinct metabolic networks operating in cancer cells, especially when its expression is deregulated. The gene discussed is SIRT7; the disease is neoplasm.